In addition, the targets of zonisamide, including SCN5A, SCN4B and SCN1B, are associated with relevant pathways in AF, such as the regulation of cardiac muscle cell membrane repolarization and depolarization (Supplementary Fig. 15). The gene discussed is SCN1B; the disease is atrial fibrillation.